ENDO 2023: Call for Abstracts

ENDO 2023 will take place on June 15-18, 2023, in Chicago, IL. Read the following Abstract Submission Guidelines prior to submitting your abstract. If you have any questions, email [email protected].  

Abstracts will accepted until Monday, December 19, 2022, at 1pm EST.  Late-breaking abstracts will be accepted April 2-22, 2023.

• Before proceeding with submission, review the submission guidelines and instructions. 
• Abstract submission does not automatically register you for ENDO. Presenting authors must be registered for your abstract to be included in the ENDO 2023 program. 
• All submissions require payment of the non-refundable $90 abstract handling fee. 
• Receipts for the non-refundable $90 abstract handling fee are available within the abstract submission site. To access, login with the submitting author’s username and password.  
• The abstract character limit is 2,500 characters, including punctuation and symbols, but not spaces.

Why Present Your Science at ENDO 2023? 

Coverage for Your Research 
Press coverage for ENDO generates thousands of news stories reaching millions of monthly visitors to several major media outlets. 

See Your Work Published 
Your role in advancing essential knowledge is imperative in saving lives and improving health worldwide. All accepted abstracts will be published in a supplemental issue of Journal of the Endocrine Society to ensure maximum exposure.  

Find Likeminded Colleagues 
Foster new relationships and meet collaborators for future research opportunities. 

Generate Media Buzz 

The media look to ENDO to discover the latest groundbreaking research and treatments. Watch ENDO 2022 press conferences and check out some of our press releases featuring top abstracts: 

• COVID-19 pandemic stress impacts ovulation 
• Study finds long-term 10% weight loss with anti-obesity medications and lifestyle changes 
• Teens ate less ultra-processed food consumption during pandemic, reversing trend of three decades 
• Moderation may disrupt addictive nature of wireless mobile devices and adverse health outcomes
• Cost of mental health disorders linked with polycystic ovary syndrome almost $6 billion in 2021